Conventional therapies for cancer such as chemotherapy and radiotherapy remain a mainstay in treatment, but in many cases a targeted approach is lacking, and patients can be vulnerable to drug resistance. In recent years, novel concepts have been emerging to improve the traditional therapeutic options in cancers with poor survival outcomes. New therapeutic strategies involving areas like energy metabolism and extracellular vesicles along with advances in immunotherapy and nanotechnology are driving the next generation of cancer treatments. The development of fields such as theranostics in nanomedicine is also opening new doors for targeted drug delivery and nano-imaging. Here we discuss the use of innovative technologies presented at the Irish Association for Cancer Research (IACR) Annual Meeting, highlighting examples of where new approaches may lead to promising new treatment options for a range of cancer types.
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Scientific Tracks Abstracts: Journal of Clinical Case Reports
Scientific Tracks Abstracts: Journal of Clinical Case Reports
Posters & Accepted Abstracts: Journal of AIDS & Clinical Research
Posters & Accepted Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Accepted Abstracts: Journal of AIDS & Clinical Research
Accepted Abstracts: Journal of AIDS & Clinical Research
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report